p16 as a prognostic indicator in ovarian/tubal high‐grade serous carcinoma

1. Liu H, Shi J, Wilkerson ML et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am. J. Clin. Pathol. 2012; 138; 57–64. 2. Miettinen M, McCue PA, Sarlomo-Rikala M et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am. J. Surg. Pathol. 2014; 38; 13–22. 3. Prat J, Cao D, Carinelli SG, Nogales FF, Vang R, Zaloudek CJ. Germ cell tumours. In Kurman RJ, Carcangiu ML, Herrington S, Young RH eds. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer, 2014; 57–62. 4. Nogales FF, Preda O, Nicolae A. Yolk sac tumours revisited. A review of their many faces and names. Histopathology 2012; 60; 1023–1033. 5. Nogales FF, Quinonez E, Lopez-Marin L et al. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac. Histopathology 2014; 65; 51–59. 6. Heifetz SA, Cushing B, Giller R et al. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children’s Cancer Group. Am. J. Surg. Pathol. 1998; 22; 1115–1124. 7. Nogales FF, Bergeron C, Carvia RE et al. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am. J. Surg. Pathol. 1996; 20; 1056–1066. 8. Preda O, Dema A, Iacob M et al. Urothelial carcinoma of the renal pelvis with simultaneous trophoblastic and malignant clear cell endodermal-type differentiation. Virchows Arch. 2012; 460; 353–356. 9. Yang Z, Tang LH, Klimstra DS. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am. J. Surg. Pathol. 2011; 35; 853–860. 10. Debacker C, Catala M, Labastie MC. Embryonic expression of the human GATA-3 gene. Mech. Dev. 1999; 85; 183–187.

[1]  B. Gallie,et al.  Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma , 2014, Modern Pathology.

[2]  O. Preda,et al.  A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac , 2014, Histopathology.

[3]  Markku Miettinen,et al.  GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors , 2014, The American journal of surgical pathology.

[4]  M. Wilkerson,et al.  Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. , 2012, American journal of clinical pathology.

[5]  F. Nogales,et al.  Yolk sac tumours revisited. A review of their many faces and names , 2012, Histopathology.

[6]  F. Nogales,et al.  Urothelial carcinoma of the renal pelvis with simultaneous trophoblastic and malignant clear cell endodermal-type differentiation , 2012, Virchows Archiv.

[7]  P. Maxwell,et al.  BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer. , 2011, Gynecologic oncology.

[8]  Laura H. Tang,et al.  Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification , 2011, The American journal of surgical pathology.

[9]  P. Kelly,et al.  Increased p16 Expression in High-grade Serous and Undifferentiated Carcinoma Compared With Other Morphologic Types of Ovarian Carcinoma , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[10]  A. Malpica,et al.  High‐grade ovarian serous carcinoma exhibits significantly higher p16 expression than low‐grade serous carcinoma and serous borderline tumour , 2007, Histopathology.

[11]  M. Catala,et al.  Embryonic expression of the human GATA-3 gene , 1999, Mechanisms of Development.

[12]  C. Stolar,et al.  Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. , 1998, The American journal of surgical pathology.

[13]  C. Bergeron,et al.  Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. , 1996, The American journal of surgical pathology.